Investor

Aurelium Ventures

Last cheque observed Jan 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series A

Cheques on record
0%of best year0cheques in 12 months, 1 on record
Since the last cheque663days00hrs00min00sec
Median round$11MRounds led0 of 1
Pitch Aurelium Ventures

Aurelium Ventures highlights

  1. 01

    1 rounds on record

  2. 02

    Mostly Series A: 100% of its rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first1 appearances

  1. 2025

    1 round

  2. Jan
    Oxford Cancer Analytics (OXcan)Series A · GB · We Venture Capital$11MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Quick answers about Aurelium Ventures

What does Aurelium Ventures invest in?

Aurelium Ventures invests most often at Series A (100% of the rounds on record).

How active is Aurelium Ventures?

1 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2025.

What has Aurelium Ventures invested in recently?

Its most recent investments on record: Oxford Cancer Analytics (OXcan) (Series A, Jan 2025).

How big are Aurelium Ventures's cheques?

The median round it joins is $11M.

Is Aurelium Ventures investing now?

No investments in the last 12 months; the latest was in Jan 2025.

What kind of investor is Aurelium Ventures?

Aurelium Ventures is a VC firm.

Where does this information on Aurelium Ventures come from?

From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it